Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-ALK7, the company’s second ...
H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on Arrowhead (ARWR) to $80 from $60 and keeps a Buy rating on the ...
Arrowhead (ARWR) announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-ALK7, the ...
Zacks Small Cap Research on MSN7h
ARWR: License and Collaboration Deal with Sarepta Includes $825 Million Upon Closing…ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Collaboration Deal with Sarepta Includes $825 Million Upon Closing On November 26, 2024, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced ...
Sarepta has acquired the global rights to develop ARO-DUX4 and ARO-DM1, two RNAi therapeutic candidates for types of muscular ...
BioVigil, the leader in electronic hand hygiene technology solutions for healthcare facilities, announces that its Board of Managers has appointed Erik Axter as its new Chief Executive Officer, ...
A quaint and peaceful Hudson Valley retreat is expanding its footprint in the wedding events space, with help from Kennedy ...
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...
From birth to death, tech is stretching the boundaries of biology. In this episode of Posthuman, we explore the discoveries that could transform reproduction, healthcare and how we die. (Source ...
China has enacted an immediate ban on the export of dual-use items related to gallium, germanium, antimony, and superhard materials to the U.S., in response to Washington's latest crackdown on the ...
Current soldiers and reservists can now use digital prescriptions as well as IDF identification cards to withdraw medications from Super-Pharm. Information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback